BioNTech, a pioneer in mRNA-based medicines and next-generation immunotherapies, has longstanding scientific and translational ties to Penn. Through the PxB Fund, BioNTech aims to deepen its ...
Philadelphia venture firm Osage University Partners will manage the capital, only available to university-affiliated companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback